Literature DB >> 20018654

Probiotics promote gut health through stimulation of epithelial innate immunity.

Cristiano Pagnini1, Rubina Saeed, Giorgos Bamias, Kristen O Arseneau, Theresa T Pizarro, Fabio Cominelli.   

Abstract

Probiotic formulations are widely available and have a variety of proposed beneficial effects, including promotion of gut health. The mechanisms of action of probiotic bacteria in the intestine are still unclear but are generally attributed to an antiinflammatory effect. Here, we demonstrate that the multiple probiotic formulation VSL#3 prevents the onset of intestinal inflammation by local stimulation of epithelial innate immune responses (i.e., increased production of epithelial-derived TNF-alpha and restoration of epithelial barrier function in vivo). We also demonstrate that probiotic bacteria stimulate epithelial production of TNF-alpha and activate NF-kappaB in vitro. Our results support the hypothesis that probiotics promote gut health through stimulation, rather than suppression, of the innate immune system. Furthermore, our findings provide the perspective that defects in innate immunity may play a critical role in the pathogenesis and progression of intestinal disorders, such as inflammatory bowel disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20018654      PMCID: PMC2806692          DOI: 10.1073/pnas.0910307107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Th1-type responses mediate spontaneous ileitis in a novel murine model of Crohn's disease.

Authors:  M M Kosiewicz; C C Nast; A Krishnan; J Rivera-Nieves; C A Moskaluk; S Matsumoto; K Kozaiwa; F Cominelli
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

Review 2.  Inflammatory bowel disease.

Authors:  Daniel K Podolsky
Journal:  N Engl J Med       Date:  2002-08-08       Impact factor: 91.245

3.  Bacterial-reactive T regulatory cells inhibit pathogenic immune responses to the enteric flora.

Authors:  Yingzi Cong; Casey T Weaver; Audrey Lazenby; Charles O Elson
Journal:  J Immunol       Date:  2002-12-01       Impact factor: 5.422

4.  Emergence of perianal fistulizing disease in the SAMP1/YitFc mouse, a spontaneous model of chronic ileitis.

Authors:  Jesús Rivera-Nieves; Giorgos Bamias; Alda Vidrich; Marco Marini; Theresa T Pizarro; Marcia J McDuffie; Christopher A Moskaluk; Steven M Cohn; Fabio Cominelli
Journal:  Gastroenterology       Date:  2003-04       Impact factor: 22.682

5.  Probiotic bacteria enhance murine and human intestinal epithelial barrier function.

Authors:  K Madsen; A Cornish; P Soper; C McKaigney; H Jijon; C Yachimec; J Doyle; L Jewell; C De Simone
Journal:  Gastroenterology       Date:  2001-09       Impact factor: 22.682

6.  Enhanced intestinal inflammation induced by dextran sulfate sodium in tumor necrosis factor-alpha deficient mice.

Authors:  Yuji Naito; Tomohisa Takagi; Osamu Handa; Takeshi Ishikawa; Shuji Nakagawa; Taiji Yamaguchi; Norimasa Yoshida; Masato Minami; Masakazu Kita; Jiro Imanishi; Toshikazu Yoshikawa
Journal:  J Gastroenterol Hepatol       Date:  2003-05       Impact factor: 4.029

7.  Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial.

Authors:  Stephen B Hanauer; Brian G Feagan; Gary R Lichtenstein; Lloyd F Mayer; S Schreiber; Jean Frederic Colombel; Daniel Rachmilewitz; Douglas C Wolf; Allan Olson; Weihang Bao; Paul Rutgeerts
Journal:  Lancet       Date:  2002-05-04       Impact factor: 79.321

8.  Tumor necrosis factor alpha-dependent up-regulation of Lrh-1 and Mrp3(Abcc3) reduces liver injury in obstructive cholestasis.

Authors:  Alan Bohan; Wen-Sheng Chen; Lee A Denson; Matthew A Held; James L Boyer
Journal:  J Biol Chem       Date:  2003-07-01       Impact factor: 5.157

9.  Quantitative detection of probiotic Bifidobacterium strains in bacterial mixtures by using real-time PCR.

Authors:  Beatrice Vitali; Marco Candela; Diego Matteuzzi; Patrizia Brigidi
Journal:  Syst Appl Microbiol       Date:  2003-06       Impact factor: 4.022

10.  The two faces of IKK and NF-kappaB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion.

Authors:  Lee-Wei Chen; Laurence Egan; Zhi-Wei Li; Florian R Greten; Martin F Kagnoff; Michael Karin
Journal:  Nat Med       Date:  2003-04-07       Impact factor: 53.440

View more
  118 in total

1.  Distinct compartmentalization of NF-κB activity in crypt and crypt-denuded lamina propria precedes and accompanies hyperplasia and/or colitis following bacterial infection.

Authors:  Parthasarathy Chandrakesan; Ishfaq Ahmed; Anisha Chinthalapally; Pomila Singh; Shanjana Awasthi; Shrikant Anant; Shahid Umar
Journal:  Infect Immun       Date:  2011-12-05       Impact factor: 3.441

Review 2.  Relationship between intestinal microbiota and colorectal cancer.

Authors:  Gokhan Cipe; Ufuk Oguz Idiz; Deniz Firat; Huseyin Bektasoglu
Journal:  World J Gastrointest Oncol       Date:  2015-10-15

3.  Immunomodulatory activity of two potential probiotic strains in LPS-stimulated HT-29 cells.

Authors:  Raj Kumar Duary; Virender Kumar Batish; Sunita Grover
Journal:  Genes Nutr       Date:  2014-03-30       Impact factor: 5.523

Review 4.  Human microbiota, blood group antigens, and disease.

Authors:  D Rose Ewald; Susan C J Sumner
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2018-01-09

Review 5.  Probiotics or pro-healers: the role of beneficial bacteria in tissue repair.

Authors:  Jovanka Lukic; Vivien Chen; Ivana Strahinic; Jelena Begovic; Hadar Lev-Tov; Stephen C Davis; Marjana Tomic-Canic; Irena Pastar
Journal:  Wound Repair Regen       Date:  2018-02-09       Impact factor: 3.617

Review 6.  Pathway-based approaches to the treatment of inflammatory bowel disease.

Authors:  Giorgos Bamias; Theresa T Pizarro; Fabio Cominelli
Journal:  Transl Res       Date:  2015-09-07       Impact factor: 7.012

Review 7.  Gut microbiota role in irritable bowel syndrome: New therapeutic strategies.

Authors:  Eleonora Distrutti; Lorenzo Monaldi; Patrizia Ricci; Stefano Fiorucci
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

8.  Probiotics and ileitis: could augmentation of TNF/NFκB activity be the answer?

Authors:  Christian Jobin
Journal:  Gut Microbes       Date:  2010-05-26

Review 9.  Gut microbiota and probiotics in colon tumorigenesis.

Authors:  Yuanmin Zhu; T Michelle Luo; Christian Jobin; Howard A Young
Journal:  Cancer Lett       Date:  2011-06-24       Impact factor: 8.679

Review 10.  Molecular dialogue between the human gut microbiota and the host: a Lactobacillus and Bifidobacterium perspective.

Authors:  Francesca Turroni; Marco Ventura; Ludovica F Buttó; Sabrina Duranti; Paul W O'Toole; Mary O'Connell Motherway; Douwe van Sinderen
Journal:  Cell Mol Life Sci       Date:  2013-03-21       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.